ANI Pharmaceuticals Inc. (ANIP)
55.60
1.44 (2.66%)
At close: Jan 15, 2025, 10:00 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | 18.78M | -47.90M | -42.60M | -22.55M | 6.09M | 15.49M | -1.08M | 3.93M | 15.38M | 28.75M | 301.00K | -27.72M | -51.61M | -46.20M | -47.53M | -17.43M | -7.58M | 2.79M | -9.65M | -12.02M | -5.96M | -3.81M | -2.61M | -3.44M | -1.41M | -2.66M |
| Depreciation & Amortization | 59.79M | 59.65M | 47.25M | 44.64M | 44.61M | 33.74M | 27.93M | 22.34M | 6.90M | 3.88M | 1.11M | 258.95K | 148.24K | 167.99K | 137.28K | 43.14K | 89.82K | 117.78K | 100.94K | 101.94K | 92.93K | 92.10K | 110.56K | 122.79K | 90.97K | 139.77K |
| Stock-Based Compensation | 20.65M | 14.60M | 10.49M | 12.94M | 9.22M | 6.78M | 6.09M | 6.07M | 3.86M | 3.42M | 4.45M | 725.63K | 1.18M | 992.76K | 1.25M | 1.10M | n/a | n/a | 351.50M | 572.54K | 193.00K | 18.00K | 18.00K | n/a | n/a | n/a |
| Other Working Capital | 19.79M | 4.20M | -7.93M | 16.09M | -4.67M | 7.62M | 1.88M | 14.90M | -2.33M | 7.91M | -3.02M | 492.67K | -132.29M | 32.44M | 27.48M | 854.59K | 7.61M | -8.98M | 101.99M | -140.38K | 263.46K | -390.08K | 405.80K | 106.80K | -472.53K | -651.71K |
| Other Non-Cash Items | 6.62M | 8.99M | 5.02M | 6.07M | 9.42M | 10.27M | 8.57M | 13.97M | 6.87M | 559.00K | 217.00K | 4.33M | -51.38M | 1.87M | 29.28M | 104.28K | 625.91K | 1.08M | 750.00K | -1 | 193.00K | -18.00K | 125.00K | n/a | n/a | 129.93K |
| Deferred Income Tax | -11.74M | -15.25M | -16.75M | -13.21M | -9.13M | -5.18M | 3.56M | -8.91M | -1.88M | -14.46M | -195.00K | 1.05M | 51.98M | 290.58K | n/a | n/a | n/a | n/a | -351.15M | n/a | -193.00K | n/a | -18.00K | n/a | n/a | n/a |
| Change in Working Capital | 24.86M | -51.30M | -84.00K | -12.63M | -14.58M | 5.97M | -5.65M | -9.93M | -13.86M | -115.00K | -11.37M | -3.93M | 1.82M | 2.78M | -1.58M | 639.38K | 7.61M | -8.98M | 151.09K | 899.28K | 151.44K | -243.90K | 551.98K | 106.80K | -472.53K | -651.71K |
| Operating Cash Flow | 118.96M | -31.20M | 3.32M | 15.27M | 45.63M | 67.07M | 39.42M | 27.47M | 17.26M | 22.03M | -5.48M | -25.28M | -47.87M | -40.10M | -18.43M | -15.54M | 739.99K | -5.00M | -8.30M | -10.44M | -5.52M | -3.96M | -1.82M | -3.21M | -1.79M | -3.04M |
| Capital Expenditures | -18.51M | -16.45M | -23.64M | -68.32M | -27.55M | -10.91M | -107.99M | -149.06M | -32.68M | -35.75M | -191.00K | -611.19K | -719.92K | -63.44K | -165.72K | -651.12K | -29.43K | -39.26K | -67.42K | -103.20K | -8.87K | -38.99K | -86.73K | -43.24K | -4.22K | -124.98K |
| Acquisitions | n/a | -33.00K | -84.49M | n/a | n/a | -16.47M | n/a | n/a | n/a | n/a | 18.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 67.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.00M | n/a | n/a | n/a | -7.96K | n/a | n/a | n/a | n/a | -11.21M | -8.01M | -392.38K | -16.10M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.03M | 11.98M | 981.00 | 13.00M | 7.70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -9.64M | 750.00K | 2.65M | -62.19M | -20.91M | -5.17M | -97.62M | -5.00M | -30.50M | -34.63M | 2.26M | n/a | n/a | 3.08K | -165.72M | n/a | n/a | n/a | -67.42M | -103.20K | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -18.51M | -15.74M | -105.48M | -68.32M | -27.55M | -27.38M | -107.99M | -154.06M | -32.68M | -35.75M | 20.27M | -619.15K | -719.92K | -60.37K | 2.86M | 11.33M | -11.24M | 4.96M | 7.24M | -16.20M | -8.87K | -38.99K | -86.73K | -43.24K | -4.22K | -124.98K |
| Debt Repayment | -3.00M | -3.00M | 99.02M | -534.00K | 115.29M | -2.81M | 75.00M | n/a | n/a | 138.24M | -4.07M | n/a | -1.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 500.00K | n/a | 4.26M |
| Common Stock Repurchased | -4.99M | -1.96M | -890.00K | -1.52M | -1.03M | -659.00K | -259.00K | -2.62M | -113.00K | n/a | -433.00K | -658 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.05K | n/a | -12 | n/a | n/a |
| Dividend Paid | -1.63M | -1.63M | -190.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -3.50M | 1.46M | 27.07M | 618.00K | -113.01M | -24.34M | -2.38M | -607.00K | 1.18M | 33.41M | 809.00K | 211.07K | 56.50K | 2.01K | 22.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58.00K | n/a | -1.88K |
| Financial Cash Flow | 67.44M | -5.13M | 194.59M | -1.44M | 1.25M | -27.82M | 72.36M | -729.00K | 1.07M | 171.65M | -3.69M | 3.47M | 67.66M | 48.45M | 33.67M | 319.38K | 18.49M | 7.38M | 197.77K | 18.68M | 9.78M | 4.38M | 3.80M | 588.04K | 4.23M | 4.26M |
| Net Cash Flow | 167.89M | -52.07M | 92.43M | -54.49M | 19.33M | 11.88M | 3.78M | -127.32M | -14.35M | 157.93M | 11.09M | -22.43M | 19.07M | 8.30M | 18.10M | -3.89M | 8.00M | 7.34M | -859.38K | -7.96M | 4.25M | 381.31K | 1.89M | -2.66M | 2.43M | 1.09M |
| Free Cash Flow | 100.45M | -47.66M | -20.32M | -53.05M | 18.08M | 56.16M | -68.57M | -121.59M | -15.42M | -13.72M | -5.67M | -25.89M | -48.59M | -40.16M | -18.60M | -16.19M | 710.56K | -5.04M | -8.36M | -10.55M | -5.53M | -4.00M | -1.91M | -3.25M | -1.79M | -3.17M |